Why Neurology Trials Have Some of the Highest Screen Failure Rates and How Patiro Reduces Them
Neurology clinical trial recruitment breaks down at screening, not awareness. Many protocols depend on diagnostic workups, narrow scale thresholds, imaging confirmation, or symptom timing that cannot be verified from a first inquiry. Add fluctuating symptoms, comorbidities, and complex medication histories, and a large “interested” pool turns into screen failures.
Site variation adds avoidable loss. Referral pathways differ by region, and access to neurologists and specialty testing can delay confirmation. In acute and clinic-based populations, clinician outreach influences which patients get identified and referred. In one acute stroke recruitment analysis, presentations to neurology clinical staff were the most common promotional method used by sites.
Patiro works around these realities with protocol-specific targeting and structured pre-screening before routing patients to sites. We run digital outreach alongside clinician and community channels, then pre-qualify on the criteria that most often drive neurology screen failures: diagnosis certainty, symptom profile and timing, prior treatment, functional status, and caregiver availability when relevant. Sites see fewer low-fit referrals and spend less time on nonproductive screening visits.
Patiro’s Experience in Neurology Clinical Trials
Patiro supports neurology trials across drugs, devices, and procedures. Recruitment plans are built around how patients enter real care pathways, and not generic audience targeting.
Alzheimer’s disease, Parkinson’s disease, MS, stroke, and rare neurology studies each require different referral partners, messaging, and caregiver involvement. We plan for those differences up front. Patiro has supported patient recruitment across a range of neurological complexity, from pediatric-onset conditions like Pediatric Acute-onset Neuropsychiatric Syndrome, to neurodegenerative diseases like Alzheimer's and Frontotemporal Dementia, to autoimmune and peripheral nerve conditions like Myasthenia Gravis and Small Fiber Neuropathy.
Each brings a different diagnostic pathway, caregiver dynamic, and pace of disease progression, which shapes how outreach and pre-screening need to work. Additional experience includes Type 2 Diabetes and Polycythemia Vera, where diabetic neuropathy and hyperviscosity-related neurological symptoms bring patients into overlapping care pathways.
Why Partner With Patiro For Your Neurology Trial
Patiro runs global full-service and FSP models for site management and patient recruitment. Sponsors and CROs can fit support to the study, the countries, and the site network.
Channel mix follows the protocol. We run digital campaigns, clinician-facing outreach, and local community pathways, then coordinate with sites so referral flow matches site capacity and visit schedules.
Patiro offers a Pay Only per Enrolled Patient model. It ties cost to enrolled participants, and not top-of-funnel volume that does not convert. Retention support continues after first contact, which matters in neurology where caregiver burden and visit complexity often drive discontinuations.
Contact us to discuss how we can help with clinical trial recruitment for your neurology trial.
Frequently Asked Questions
How does Patiro recruit patients for neurology trials?
We use digital outreach, community channels, databases and protocol-specific pre-screening to improve referral quality before site screening.
What types of neurology studies can Patiro support?
Patiro can support neurology clinical trials involving drugs, devices, and procedures, including complex and rare CNS populations.
How do you support caregivers in neurology trial recruitment?
Caregivers are often the primary point of contact for conditions like Alzheimer's, Frontotemporal Dementia, and PANS. We build outreach and pre-screening to address caregivers directly where appropriate, and account for their role in scheduling, consent discussions, and ongoing communication throughout the trial.
How do you support retention in long-running or progressive neurology trials?
Progressive conditions can affect a patient's ability to participate as a trial continues. Patiro keeps contact consistent through screening and beyond, flag changes in capacity or circumstance early, and coordinate with sites on logistics like transportation and visit scheduling to reduce avoidable dropout.
How does Patiro help reduce screen failures?
We pre-qualify on the criteria that commonly drive neurology screen failures and route higher-fit patients to sites.
Can Patiro support both sponsor-led and CRO-led studies?
Yes. We work with sponsors and CROs through full-service delivery or FSP support, depending on your resourcing model.
How does pricing work?
Patiro has a pay-per-enrolled-patient model, which means sponsors pay for enrolled participants rather than referral volume. This keeps budget risk low and aligns Patiro's incentives directly with the sponsor's enrollment targets.
How fast can you start neurology patient recruitment?
Launch timing depends on protocol clarity, geographies, and the site plan. Once pre-screening and referral pathways are confirmed, Patiro can mobilise quickly. Having supported rescue studies where enrollment had already fallen behind, we know how to move fast without compromising referral quality.
